{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:22:23Z","timestamp":1791044543467,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":5191,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1006\/viro.1999.9679","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:00:16Z","timestamp":1032426016000},"page":"314-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["HTLV-I-Infected T Cells Evade the Antiproliferative Action of IFN-\u03b2"],"prefix":"10.1006","volume":"257","author":[{"given":"Derek","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy J.","family":"Buckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hafler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"H\u00f6llsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/viro.1999.9679_RF1","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1002\/j.1460-2075.1994.tb06932.x","article-title":"Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-\u03b1 and IFN-\u03b2","volume":"13","author":"Abramovich","year":"1994","journal-title":"EMBO J."},{"key":"10.1006\/viro.1999.9679_RF2","first-page":"1645","article-title":"Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: Possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4Waf1\/Cip1\/Sdi1","volume":"12","author":"Akagi","year":"1996","journal-title":"Oncogene"},{"key":"10.1006\/viro.1999.9679_RF3","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1002\/j.1460-2075.1994.tb06898.x","article-title":"Activation of JAK kinases and STAT proteins by interleukin-2 and interferon \u03b1, but not the T cell antigen receptor, in human T lymphocytes","volume":"13","author":"Beadling","year":"1994","journal-title":"EMBO J."},{"key":"10.1006\/viro.1999.9679_RF4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","article-title":"Direct analysis of viral-specific CD8+","volume":"162","author":"Bieganowska","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/viro.1999.9679_RF5","series-title":"Human T Cell Lymphotropic Virus Type I","article-title":"Biology of HTLV-I: Host cell interactions","author":"Brady","year":"1996"},{"key":"10.1006\/viro.1999.9679_RF6","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00042560-199600001-00018","article-title":"HTLV-I-induced T cell activation","volume":"13","author":"Buckle","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retroviruses"},{"key":"10.1006\/viro.1999.9679_RF7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V88.5.1551.1551","article-title":"p53 functional impairment and high p21waf1\/cip1","volume":"88","author":"Cereseto","year":"1996","journal-title":"Blood"},{"key":"10.1006\/viro.1999.9679_RF8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.272.5262.719","article-title":"Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1\/CIP1","volume":"272","author":"Chin","year":"1996","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bjc.1988.111","article-title":"Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon","volume":"57","author":"D'Onofrio","year":"1988","journal-title":"Br. J. Cancer"},{"key":"10.1006\/viro.1999.9679_RF11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1006\/viro.1999.9679_RF12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease","volume":"177","author":"Elovaara","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.1999.9679_RF13","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","article-title":"Molecular mechanisms of human T cell leukemia\/lymphotropic virus type I infection","volume":"86","author":"Franchini","year":"1995","journal-title":"Blood"},{"key":"10.1006\/viro.1999.9679_RF14","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1073\/pnas.92.17.7779","article-title":"Interleukin 2 signaling involves the phosphorylation of Stat proteins","volume":"92","author":"Frank","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V75.2.428.428","article-title":"High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis","volume":"75","author":"Gessain","year":"1990","journal-title":"Blood"},{"key":"10.1006\/viro.1999.9679_RF16","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and ziduvine","volume":"332","author":"Gill","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/viro.1999.9679_RF17","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1021\/bi980073j","article-title":"Mapping human interferon\/alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human\/bovine IFNAR-1 chimeras","volume":"37","author":"Goldman","year":"1998","journal-title":"Biochemistry"},{"key":"10.1006\/viro.1999.9679_RF18","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1073\/pnas.86.8.2878","article-title":"Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification","volume":"86","author":"Greenberg","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF19","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","article-title":"Direct visualization of antigen-specific T cells: HTLV-I Tax11\u201319-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients","volume":"95","author":"Greten","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Treatment of adult-T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/viro.1999.9679_RF21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0404.1997.tb08156.x","article-title":"Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I","volume":"S169","author":"H\u00f6llsberg","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/viro.1999.9679_RF22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.153.2.566","article-title":"Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-\u03b21-induced suppression","volume":"153","author":"H\u00f6llsberg","year":"1994","journal-title":"J. Immunol."},{"key":"10.1006\/viro.1999.9679_RF23","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1073\/pnas.92.9.4036","article-title":"Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand","volume":"92","author":"H\u00f6llsberg","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF24","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.148.10.3256","article-title":"Characterization of HTLV-I in vivo infected T cell clones: IL-2 independent growth of nontransformed T cells","volume":"148","author":"H\u00f6llsberg","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/viro.1999.9679_RF25","doi-asserted-by":"crossref","first-page":"11284","DOI":"10.1073\/pnas.92.24.11284","article-title":"A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons \u03b1 and \u03b2 and alters macrophage responses","volume":"92","author":"Hwang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-5728(95)00101-7","article-title":"Anti-viral and immunomodulatory effects of interferon-\u03b1 on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"61","author":"Ijichi","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1006\/viro.1999.9679_RF27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","article-title":"Circulating CD8+","volume":"348","author":"Jacobson","year":"1990","journal-title":"Nature"},{"key":"10.1006\/viro.1999.9679_RF28","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1128\/jvi.67.6.3134-3141.1993","article-title":"The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2\/LFA-3 activation pathway","volume":"67","author":"Kimata","year":"1993","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9679_RF29","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.4049\/jimmunol.142.12.4493","article-title":"Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2 independent, HTLV-I-transformed T cell lines","volume":"142","author":"Koga","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/viro.1999.9679_RF30","doi-asserted-by":"crossref","first-page":"21872","DOI":"10.1074\/jbc.272.35.21872","article-title":"Regulation of interferon-\u03b1 responsiveness by the duration of Janus kinase activity","volume":"272","author":"Lee","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.1999.9679_RF31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jir.1995.15.55","article-title":"Human type I interferon receptor, IFNAR, is a heavily glycosylated 120\u2013130 kD membrane protein","volume":"15","author":"Ling","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1006\/viro.1999.9679_RF32","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/jvi.71.3.1956-1962.1997","article-title":"Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a","volume":"71","author":"Low","year":"1997","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9679_RF33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"key":"10.1006\/viro.1999.9679_RF34","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"M\u00fcller","year":"1994","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF35","first-page":"203","article-title":"Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy","volume":"103","author":"Nagasato","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1006\/viro.1999.9679_RF36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90244-S","article-title":"Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis","volume":"46","author":"Noronha","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1006\/viro.1999.9679_RF37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01310623","article-title":"Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I)","volume":"115","author":"Oka","year":"1990","journal-title":"Arch. Virol."},{"key":"10.1006\/viro.1999.9679_RF38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/37648","article-title":"Antiproliferative action of interferon-a requires components of T-cell receptor signalling","volume":"390","author":"Petrocoin","year":"1997","journal-title":"Nature"},{"key":"10.1006\/viro.1999.9679_RF39","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1016\/S0021-9258(17)32371-2","article-title":"Tyrosine phosphorylation of the \u03b1 and \u03b2 subunits of the type I interferon receptor","volume":"269","author":"Platanias","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1006\/viro.1999.9679_RF40","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type I","volume":"64","author":"Richardson","year":"1990","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9679_RF41","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood.V89.9.3303","article-title":"Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I","volume":"89","author":"Richardson","year":"1997","journal-title":"Blood"},{"key":"10.1006\/viro.1999.9679_RF42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/JVI.72.1.633-640.1998","article-title":"Stimulation of cyclin-dependent kinase activity and G1","volume":"72","author":"Schmitt","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.1999.9679_RF43","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4049\/jimmunol.157.7.2932","article-title":"Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation","volume":"157","author":"Scholz","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/viro.1999.9679_RF44","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer and cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF45","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.7690989","article-title":"A single phosphotyrosine residue of Stat-91 required for gene activation by interferon-\u03b3","volume":"261","author":"Shuai","year":"1993","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF46","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/j.1460-2075.1996.tb00505.x","article-title":"HTLV-I Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A","volume":"15","author":"Suzuki","year":"1996","journal-title":"EMBO J."},{"key":"10.1006\/viro.1999.9679_RF47","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1006\/viro.1999.9679_RF48","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.89.6.2110","article-title":"T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones","volume":"89","author":"Wucherpfennig","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.1999.9679_RF49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1693015","article-title":"Shared human T cell receptor V\u03b2 usage to immunodominant regions of myelin basic protein","volume":"248","author":"Wucherpfennig","year":"1990","journal-title":"Science"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682299996794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682299996794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:58:07Z","timestamp":1758581887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682299996794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0042682299996794"],"URL":"https:\/\/doi.org\/10.1006\/viro.1999.9679","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTLV-I-Infected T Cells Evade the Antiproliferative Action of IFN-\u03b2","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.1999.9679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}